Susquehanna International Group
BMY icon

Susquehanna International Group’s Bristol-Myers Squibb BMY Stock Holding History

Susquehanna International Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$287M Sell
4,730,900
-2,964,800
-39% -$173M 0.03% 399
2025
Q4 		$415M Sell
7,695,700
-100,000
-1% -$4.81M 0.05% 303
2025
Q3 		$352M Buy
7,795,700
+132,100
+2% +$6.17M 0.04% 359
2025
Q2 		$355M Buy
7,663,600
+2,670,500
+53% +$131M 0.05% 297
2025
Q1 		$305M Buy
4,993,100
+636,300
+15% +$37.1M 0.05% 293
2024
Q4 		$246M Sell
4,356,800
-3,395,000
-44% -$190M 0.04% 357
2024
Q3 		$401M Sell
7,751,800
-1,743,500
-18% -$81.8M 0.07% 233
2024
Q2 		$394M Buy
9,495,300
+5,343,700
+129% +$239M 0.07% 201
2024
Q1 		$225M Sell
4,151,600
-260,600
-6% -$13.3M 0.04% 376
2023
Q4 		$226M Buy
4,412,200
+1,642,100
+59% +$86.2M 0.04% 348
2023
Q3 		$161M Buy
2,770,100
+904,900
+49% +$55.4M 0.03% 427
2023
Q2 		$119M Sell
1,865,200
-675,900
-27% -$45.3M 0.02% 536
2023
Q1 		$176M Sell
2,541,100
-694,900
-21% -$49M 0.04% 396
2022
Q4 		$233M Buy
3,236,000
+77,500
+2% +$5.84M 0.06% 291
2022
Q3 		$225M Sell
3,158,500
-82,600
-3% -$5.99M 0.06% 267
2022
Q2 		$250M Buy
3,241,100
+543,400
+20% +$41.4M 0.06% 246
2022
Q1 		$197M Sell
2,697,700
-3,035,800
-53% -$204M 0.03% 405
2021
Q4 		$357M Buy
5,733,500
+806,800
+16% +$47.3M 0.05% 295
2021
Q3 		$292M Buy
4,926,700
+2,426,000
+97% +$160M 0.04% 384
2021
Q2 		$167M Sell
2,500,700
-256,100
-9% -$16.7M 0.02% 580
2021
Q1 		$174M Sell
2,756,800
-2,230,100
-45% -$139M 0.03% 505
2020
Q4 		$309M Buy
4,986,900
+296,200
+6% +$18.2M 0.05% 288
2020
Q3 		$283M Sell
4,690,700
-933,400
-17% -$56.2M 0.05% 262
2020
Q2 		$331M Sell
5,624,100
-772,000
-12% -$46.2M 0.08% 198
2020
Q1 		$357M Sell
6,396,100
-3,426,700
-35% -$209M 0.11% 142
2019
Q4 		$631M Buy
9,822,800
+728,200
+8% +$41.7M 0.18% 84
2019
Q3 		$461M Buy
9,094,600
+786,300
+9% +$37M 0.15% 108
2019
Q2 		$377M Sell
8,308,300
-4,166,900
-33% -$194M 0.14% 114
2019
Q1 		$595M Buy
12,475,200
+9,191,700
+280% +$458M 0.24% 56
2018
Q4 		$171M Sell
3,283,500
-739,800
-18% -$39.7M 0.07% 250
2018
Q3 		$250M Sell
4,023,300
-1,350,500
-25% -$80.1M 0.08% 203
2018
Q2 		$297M Buy
5,373,800
+1,600,400
+42% +$86.4M 0.1% 163
2018
Q1 		$239M Sell
3,773,400
-1,622,700
-30% -$104M 0.09% 188
2017
Q4 		$331M Buy
5,396,100
+210,200
+4% +$13.1M 0.12% 131
2017
Q3 		$331M Sell
5,185,900
-1,472,700
-22% -$86M 0.13% 123
2017
Q2 		$371M Sell
6,658,600
-485,100
-7% -$26.4M 0.16% 102
2017
Q1 		$388M Buy
7,143,700
+1,708,700
+31% +$93.7M 0.2% 80
2016
Q4 		$318M Sell
5,435,000
-1,888,300
-26% -$103M 0.16% 102
2016
Q3 		$395M Buy
7,323,300
+5,804,800
+382% +$373M 0.19% 75
2016
Q2 		$112M Sell
1,518,500
-66,600
-4% -$4.71M 0.06% 281
2016
Q1 		$101M Sell
1,585,100
-851,200
-35% -$53.7M 0.05% 314
2015
Q4 		$168M Sell
2,436,300
-1,627,800
-40% -$108M 0.08% 214
2015
Q3 		$241M Buy
4,064,100
+1,484,800
+58% +$94.2M 0.1% 164
2015
Q2 		$172M Sell
2,579,300
-395,200
-13% -$26M 0.07% 241
2015
Q1 		$192M Sell
2,974,500
-863,500
-22% -$54.1M 0.09% 207
2014
Q4 		$227M Sell
3,838,000
-107,300
-3% -$6.05M 0.09% 209
2014
Q3 		$202M Sell
3,945,300
-240,000
-6% -$12M 0.08% 215
2014
Q2 		$203M Buy
4,185,300
+732,300
+21% +$36.1M 0.09% 185
2014
Q1 		$179M Sell
3,453,000
-653,300
-16% -$34.8M 0.08% 203
2013
Q4 		$218M Buy
4,106,300
+1,247,600
+44% +$63.6M 0.1% 142
2013
Q3 		$132M Buy
2,858,700
+744,200
+35% +$32.7M 0.07% 233
2013
Q2 		$94.5M Buy
+2,114,500
New +$91.8M 0.05% 286

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's BMY Position: Q1 2026 in Review

Susquehanna International Group reduced its Bristol-Myers Squibb (BMY) stake by 19% in Q1 2026, selling an estimated $8.43M and leaving 600,889 shares worth $36.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1554.

Susquehanna International Group first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $294M in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Susquehanna International Group held 600,889 shares of Bristol-Myers Squibb worth $36.4M as of Q1 2026.
  • Susquehanna International Group sold 144,605 Bristol-Myers Squibb shares in Q1 2026, an estimated $8.43M.
  • Bristol-Myers Squibb made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1554 holding.
  • Susquehanna International Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
  • Susquehanna International Group's Bristol-Myers Squibb position peaked at $294M in Q4 2019.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.